Chronic Obstructive Pulmonary Disease (COPD) and Emphysema in Emergency Medicine Questions & Answers

1. Hurst JR, Vestbo J, Anzueto A, Locantore N, Müllerova H, Tal-Singer R, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010 Sep 16. 363(12):1128-38. [QxMD MEDLINE Link].

2. [Guideline] Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Bethesda (MD): Global Initiative for Chronic Obstructive Lung Disease (GOLD). 2008. [Full Text].

3. Siddiqi A, Sethi S. Optimizing antibiotic selection in treating COPD exacerbations. Int J Chron Obstruct Pulmon Dis. 2008. 3(1):31-44. [QxMD MEDLINE Link]. [Full Text].

4. Haffner CA, Kendall MJ. Metabolic effects of beta 2-agonists. J Clin Pharm Ther. 1992 Jun. 17 (3):155-64. [QxMD MEDLINE Link].

5. Lemanske RF. Beta agonists in asthma: Acute administration and prophylactic use. Uptodate.com. Available at http://www.uptodate.com/contents/beta-agonists-in-asthma-acute-administration-and-prophylactic-use. June 1, 2017; Accessed: May 16, 2018.

6. Austin MA, Wills KE, Blizzard L, Walters EH, Wood-Baker R. Effect of high flow oxygen on mortality in chronic obstructive pulmonary disease patients in prehospital setting: randomised controlled trial. BMJ. 2010 Oct 18. 341:c5462. [QxMD MEDLINE Link]. [Full Text].

7. Pierson DJ. Indications for mechanical ventilation in adults with acute respiratory failure. Respir Care. 2002 Mar. 47(3):249-62; discussion 262-5. [QxMD MEDLINE Link].

8. [Guideline] Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease 2018 Report. Goldcopd.org. Available at https://goldcopd.org/wp-content/uploads/2017/11/GOLD-2018-v6.0-FINAL-revised-20-Nov_WMS.pdf. 2018; Accessed: October 23, 2018.

9. Mirza S, Clay RD, Koslow MA, Scanlon PD. COPD Guidelines: A Review of the 2018 GOLD Report. Mayo Clin Proc. 2018 Oct. 93 (10):1488-1502. [QxMD MEDLINE Link].

10. [Guideline] Global Initiative for Chronic Obstructive Lung Disease. Global strategy for diagnosis, management, and prevention of COPD: 2016. Available at http://goldcopd.org/gold-reports/. Accessed: June 8, 2017.

11. Hanania NA, Donohue JF. Pharmacologic interventions in chronic obstructive pulmonary disease: bronchodilators. Proc Am Thorac Soc. 2007 Oct 1. 4(7):526-34. [QxMD MEDLINE Link].

12. Chapman KR, Rennard SI, Dogra A, Owen R, Lassen C, Kramer B. Long-term Safety and Efficacy of Indacaterol, a Long-Acting {beta}2-Agonist, in Subjects With COPD: A Randomized, Placebo-Controlled Study. Chest. 2011 Jul. 140(1):68-75. [QxMD MEDLINE Link].

13. Barr RG, Rowe BH, Camargo CA Jr. Methyl-xanthines for exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2001. (1):CD002168. [QxMD MEDLINE Link].

14. Puhan MA, Vollenweider D, Latshang T, Steurer J, Steurer-Stey C. Exacerbations of chronic obstructive pulmonary disease: when are antibiotics indicated? A systematic review. Respir Res. 2007. 8:30. [QxMD MEDLINE Link].

15. Rothberg MB, Pekow PS, Lahti M, Brody O, Skiest DJ, Lindenauer PK. Antibiotic therapy and treatment failure in patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease. JAMA. 2010 May 26. 303(20):2035-42. [QxMD MEDLINE Link].

16. Daniels JM, Snijders D, de Graaff CS, Vlaspolder F, Jansen HM, Boersma WG. Antibiotics in addition to systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2010 Jan 15. 181(2):150-7. [QxMD MEDLINE Link].

17. Balter M, Weiss K. Treating acute exacerbations of chronic bronchitis and community-acquired pneumonia: how effective are respiratory fluoroquinolones?. Can Fam Physician. 2006 Oct. 52(10):1236-42. [QxMD MEDLINE Link].

18. [Guideline] Balter MS, La Forge J, Low DE, Mandell L, Grossman RF. Canadian guidelines for the management of acute exacerbations of chronic bronchitis. Can Respir J. 2003 Jul-Aug. 10 Suppl B:3B-32B. [QxMD MEDLINE Link].

Paul Kleinschmidt, MD Associate Professor of Emergency Medicine, Campbell University Jerry M Wallace School of Osteopathic Medicine; Residency Director, EM Residency Program, Campbell University/Cape Fear Valley Medical Center; Attending Physician, Cape Fear Valley Medical Center; Associate Professor of Emergency Medicine, Methodist University

Paul Kleinschmidt, MD is a member of the following medical societies: American Academy of Emergency Medicine

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Paul Blackburn, DO, FACOEP, FACEP Attending Physician, Department of Emergency Medicine, Maricopa Medical Center

Paul Blackburn, DO, FACOEP, FACEP is a member of the following medical societies: American College of Emergency Physicians, Arizona Medical Association, American College of Osteopathic Emergency Physicians, American Medical Association

Disclosure: Nothing to disclose.

Barry E Brenner, MD, PhD, FACEP Program Director, Emergency Medicine, Einstein Medical Center Montgomery

Barry E Brenner, MD, PhD, FACEP is a member of the following medical societies: Alpha Omega Alpha, American Academy of Emergency Medicine, American College of Chest Physicians, American College of Emergency Physicians, American College of Physicians, American Heart Association, American Thoracic Society, New York Academy of Medicine, New York Academy of Sciences, Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

• Print this section
• Print the entire contents of
• Print the entire contents of article